Treatment of hepatic encephalopathy

American Journal of Gastroenterology

Volumn 92, Issue 9, 1997, Pages 1429-1439

  Córdoba, Juan ^a   Blei, Andres T ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b VA Lakeside Medical Science Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOIC ACID; BROMOCRIPTINE; FLUMAZENIL; LACTITOL; LACTULOSE; METRONIDAZOLE; NEOMYCIN; PLACEBO; SORBITOL; VANCOMYCIN; ZINC;

BLOOD BRAIN BARRIER; BRAIN EDEMA; CENTRAL NERVOUS SYSTEM FUNCTION; CHRONIC LIVER DISEASE; DIET THERAPY; ELECTROLYTE DISTURBANCE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER FAILURE; PRIORITY JOURNAL; REVIEW;

BLOOD-BRAIN BARRIER; BRAIN DISEASES; CHRONIC DISEASE; HEPATIC ENCEPHALOPATHY; HUMANS; INTESTINAL DISEASES; LIVER DISEASES;

EID: 0030821371     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (3)

1. Hepatic encephalopathy. In: Sherlock S, Dooley J, eds. Diseases of the liver and the biliary system, 9th ed. Oxford: Blackwell Scientific, 1993:86-101.
2. Mullen KD, Cole M, Foley JM. Neurological deficits in "awake" cirrhotic patients on hepatic encephalopathy treatment: Missed metabolic or metal disorder? Gastroenterology 1996;111:256-7.
3. Crippin JS, Gross JB Jr, Lindor KD. Increased intracranial pressure and hepatic encephalopathy in chronic liver disease. Am J Gastroenterol 1992;87:879-82.